TZ Ref No.: TZ-B56B94C

Contract Award Awarded Contract National (NCB) Russian Federation Healthcare and Medicine Pharmaceuticals

Anti-tumor Drugs

Doc ref no. 1771404207026004911

Sector Healthcare and Medicine, Pharmaceuticals

Contract Date 29 Oct 2026

Contract Value RUB 11K

Contract Intelligence

AI opportunity notes and scope analysis for this contract award

Opportunity Notes Summarized from official procurement documents

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Official Award Result Status: Contract Awarded

Award Date: 29 Oct 2026

Awarded Contractor / Winner

ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "КОМПАНИЯ ФАРМСТОР" (ООО "КОМПАНИЯ ФАРМСТОР")

Awarded Contract Value: RUB 10,890.00

Contract Description

Official Contract Award for ANTI-TUMOR DRUGS. Awarded Contractor: ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "КОМПАНИЯ ФАРМСТОР" (ООО "КОМПАНИЯ ФАРМСТОР"). Procuring Entity: МОСКОВСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ОНКОЛОГИЧЕСКИЙ ИНСТИТУТ ИМЕНИ П.А. ГЕРЦЕНА - ФИЛИАЛ ФЕДЕРАЛЬНОГО ГОСУДАРСТВЕННОГО БЮДЖЕТНОГО УЧРЕЖДЕНИЯ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР РАДИОЛОГИИ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ. Contract ID: 1771404207026004911. Value: 10,890.00 RUB.

Procurement Requirements & Eligibility

Statutory qualifications, financial guarantees, and bidding compliance.

Commercial & Financial Terms

🛡️

Bid Security / Earnest Money Deposit (EMD)

Tender Notice Terms

Specific bid security (EMD) guarantees and waiver conditions are detailed in official bidding documents.

📄

Tender Document Fee

Tender Notice Terms

Tender documents available for review via official e-procurement portal or issuing premises.

🏦

Performance Security / Bank Guarantee (PBG)

Standard Terms

Standard performance security (typically 5%–10% of contract value) required from successful bidder.

🏛️

Financing & Funding Source

Governance Rule

Procurement financed under budgetary allocation of МОСКОВСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ОНКОЛОГИЧЕСКИЙ ИНСТИТУТ ИМЕНИ П.А. ГЕРЦЕНА - ФИЛИАЛ ФЕДЕРАЛЬНОГО ГОСУДАРСТВЕННОГО БЮДЖЕТНОГО УЧРЕЖДЕНИЯ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР РАДИОЛОГИИ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ.

Bidder Eligibility & Technical Capacity

✅

Bidder Eligibility, Turnover & Technical Qualifications

Notice Guidance

Audited financial statements, statutory clearance certificates, and demonstrated past performance required per tender docket.

Contract Award Scope & Format

📦

Contract Procedure & Award Concluded

Award Concluded

Procedure: National Competitive Bidding (NCB) • Submission Mode: Official e-Procurement Portal / Designated Desk

📋

Official Notice Specifications & Criteria

Specific technical eligibility criteria, financial thresholds, and submission formats for this procurement notice are detailed directly in the official bidding documents.

Official Tender Documents

Official bidding notice, specifications, and AI intelligence summary.

2 Available Files

OFFICIAL NOTICE

Official Tender Notice & Bidding Specification VERIFIED SOURCE

TZ Ref: TZ-B56B94C • Complete Official Notice Archive

Download Notice

AI BRIEF

AI Executive RFP Summary Brief PRO

Synthesized Executive Intelligence • Key Dates, Budget & Criteria

SOURCE ATTACHMENT

Original Procurement Portal Notice & Attachments

Direct link from МОСКОВСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ОНКОЛОГИЧЕСКИЙ ИНСТИТУТ ИМЕНИ П.А. ГЕРЦЕНА - ФИЛИАЛ ФЕДЕРАЛЬНОГО ГОСУДАРСТВЕННОГО БЮДЖЕТНОГО УЧРЕЖДЕНИЯ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР РАДИОЛОГИИ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ

Open Official Source

Contract Lifecycle & Milestones

Notice Published

29 Oct 2026, 01:00

Tender notification officially published to portal

Contract Award Issued

29 Oct 2026

Formal contract award to ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "КОМПАНИЯ ФАРМСТОР" (ООО "КОМПАНИЯ ФАРМСТОР")

Key Contract Details

Buyer Contact Information

МОСКОВСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ОНКОЛОГИЧЕСКИЙ ИНСТИТУТ ИМЕНИ П.А. ГЕРЦЕНА - ФИЛИАЛ ФЕДЕРАЛЬНОГО ГОСУДАРСТВЕННОГО БЮДЖЕТНОГО УЧРЕЖДЕНИЯ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР РАДИОЛОГИИ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ

Russian Federation

Related Procurement Opportunities

Similar tenders in Healthcare and Medicine, Pharmaceuticals

View all in sector →

View Contract Award

Anti-tumor Drugs

Contract Description

Procurement Requirements & Eligibility

Official Tender Documents

Contract Lifecycle & Milestones

Consortium & JV Partners

Key Contract Details

Buyer Contact Information

Related Procurement Opportunities

TenderZenith Assistant

Request Specialist Callback

Anti-tumor Drugs

Contract Description

Procurement Requirements & Eligibility

Official Tender Documents

Contract Lifecycle & Milestones

Consortium & JV Partners

Key Contract Details

Buyer Contact Information

Related Procurement Opportunities

Kitchen management system (V0452/2026)

Delivery of work and protective gloves (V0079/2026)

Kitchen management system (V0452/2026)